Table 2

Relative expression of TCRBV regions 1-18 in B16 G3.12 and B78–D14 tumors in PBS-treated animals as well as B78–D14 tumors in ch14.18–IL-2-treated animals

B16/7 days of PBS B16/DG2/7 days of PBS B16/DG2/7 days of ch14.18–IL-2
Animal 1Animal 2Animal 3Animal 4Animal 1Animal 2Animal 3Animal 4Animal 1Animal 2Animal 3Animal 4
% (SD)% (SD)% (SD)% (SD)% (SD)% (SD)% (SD)% (SD)% (SD)% (SD)% (SD)% (SD)
BV15.4  (0.4)4.9  (1.4)11.3  (ND)5.2  (0.7)10.9  (0.7)2.8  (1.5)9.4  (5.2)4.3  (0.9)6.1  (0.1)3.4  (0.2)4.4  (0.4)6.8  (2.2)
BV24.2  (0.9)5.1  (1.8)4.1  (ND)5.9  (1.8)5.4  (0.7)7.2  (1.9)4.4  (1.7)6.1  (0.3)5.4  (0.6)6.5  (1.1)4.7  (0.7)7.1  (0.4)
BV35.7  (0.5)4.9  (1.4)1.2  (ND)2.7  (1.1)2.9  (0.2)3.6  (1.0)4.0  (0.6)2.6  (0.3)2.5  (0.6)1.4  (0.6)2.7  (0.5)4.5  (0.9)
BV41.6  (0.6)4.2  (0.1)2.5  (ND)2.1  (0.5)3.4  (0.0)6.8  (3.2)2.2  (0.2)3.3  (0.3)2.1  (0.6)1.4  (0.1)2.2  (0.1)2.7  (1.3)
BV58.1  (0.6)6.2  (0.3)5.9  (ND)7.7  (2.3)4.7  (0.4)6.2  (1.3)5.2  (0.6)6.3  (1.7)11.6  (2.4)28.8  (1.2)17.5  (0.6)10.3  (1.4)
BV612.7  (0.4)6.4  (1.3)19.9  (ND)5.0  (0.1)5.2  (1.7)3.9  (0.4)5.9  (0.8)5.4  (0.8)6.9  (0.4)5.2  (0.8)4.1  (0.1)5.1  (0.3)
BV73.7  (1.2)4.3  (0.6)2.3  (ND)3.5  (1.9)2.9  (0.8)2.8  (0.8)3.4  (0.8)3.6  (0.3)6.0  (1.1)4.6  (1.1)6.8  (1.4)5.8  (0.2)
BV813.2  (0.2)5.3  (0.2)10.5  (ND)18.9  (1.7)30.4  (4.0)10.1  (0.7)22.7  (1.1)14.9  (1.4)18.2  (0.4)16.8  (0.5)17.7  (0.7)9.3  (3.1)
BV94.0  (1.2)4.3  (1.3)1.6  (ND)3.7  (1.1)4.0  (0.7)3.0  (0.7)6.0  (0.6)3.7  (0.1)5.8  (0.1)3.8  (0.1)3.3  (1.2)5.2  (0.4)
BV103.1  (0.8)7.4  (0.3)3.1  (ND)4.8  (0.3)4.0  (0.1)6.1  (0.3)6.0  (1.0)6.2  (0.6)5.4  (1.1)4.8  (1.3)7.8  (0.5)6.1  (0.6)
BV1111.5  (2.6)5.7  (0.1)12.6  (ND)9.0  (3.1)7.1  (1.2)5.4  (0.6)2.5  (0.4)5.4  (0.2)5.2  (0.9)6.1  (0.1)4.7  (0.8)5.3  (1.8)
BV125.8  (0.7)8.4  (1.3)10.8  (ND)6.2  (0.0)3.5  (1.3)12.9  (0.5)5.9  (1.0)15.5  (0.0)7.5  (1.9)6.7  (1.6)10.5  (0.6)7.7  (1.1)
BV139.9  (4.0)10.2  (1.4)3.4  (ND)5.1  (1.2)2.3  (0.3)4.4  (0.5)3.3  (0.0)4.7  (0.3)6.5  (1.5)3.8  (1.3)4.1  (0.8)6.8  (0.2)
BV142.8  (1.3)7.5  (2.1)2.4  (ND)3.0  (0.1)2.5  (0.5)9.8  (0.2)4.5  (0.7)3.8  (1.0)2.5  (0.0)2.3  (0.5)3.2  (0.3)5.7  (0.4)
BV153.8  (1.0)5.0  (1.0)2.2  (ND)4.5  (0.2)5.0  (0.1)6.6  (0.1)9.3  (0.4)6.2  (0.0)2.0  (0.0)1.4  (0.5)2.1  (0.3)4.5  (0.3)
BV163.9  (0.2)5.9  (1.8)4.6  (ND)6.4  (0.8)5.0  (0.2)7.2  (1.0)4.6  (0.9)7.3  (2.3)5.1  (0.1)2.8  (0.2)3.6  (0.4)4.5  (0.3)
BV170.2  (0.1)1.1  (0.9)0.7  (ND)0.4  (0.2)0.1  (0.0)0.3  (0.0)0.4  (0.1)0.1  (0.0)0.5  (0.1)0.3  (0.1)0.4  (0.4)0.2  (0.0)
BV180.4  (0.2)3.3  (0.0)0.5  (ND)5.7  (0.9)0.7  (0.1)0.9  (0.7)0.1  (0.1)0.4  (0.0)0.7  (0.4)0.2  (0.1)0.2  (0.1)0.4  (0.1)
  • The expression of each BV region was calculated as a percentage of the sum of all BV spots.